0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Drug Treatments for Gastroparesis—Why Is the Cupboard So Bare?

      Gastroenterology
      Elsevier BV

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: not found
          • Article: not found

          Gastroparesis

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.

            Patient-based symptom assessments are necessary to evaluate the effectiveness of medical treatments for gastroparesis. To summarize the development and measurement qualities of the Gastroparesis Cardinal Symptom Index (GCSI), a new measure of gastroparesis-related symptoms. The GCSI was based on reviews of the medical literature, clinician interviews and patient focus groups. The measurement qualities (i.e. reliability, validity) of the GCSI were examined in 169 gastroparesis patients. Patients were recruited from seven clinical centres in the USA to participate in this observational study. Patients completed the GCSI, SF-36 Health Survey and disability day questions at a baseline visit and again after 8 weeks. Clinicians independently rated the severity of the patients' symptoms, and both clinicians and patients rated the change in gastroparesis-related symptoms over the 8-week study. The GCSI consists of three sub-scales: post-prandial fullness/early satiety, nausea/vomiting and bloating. The internal consistency reliability was 0.84 and the test-re-test reliability was 0.76 for the GCSI total score. Significant relationships were observed between the clinician-assessed symptom severity and the GCSI total score, and significant associations were found between the GCSI scores and SF-36 physical and mental component summary scores and restricted activity and bed disability days. Patients with greater symptom severity, as rated by clinicians, reported greater symptom severity on the GCSI. The GCSI total scores were responsive to changes in overall gastroparesis symptoms as assessed by clinicians (P = 0.0002) and patients (P = 0.002). The findings of this study indicate that the GCSI is a reliable and valid instrument for measuring the symptom severity in patients with gastroparesis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis.

              The relationship between symptom improvement (SI) and acceleration of gastric emptying (GE) for different drugs used in the treatment of idiopathic and diabetic gastroparesis is uncertain. In this paper we examined the study-specific correlations between SI and GE, and we performed a meta-regression analysis of the association across multiple studies.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                Journal
                Gastroenterology
                Gastroenterology
                Elsevier BV
                00165085
                February 2023
                February 2023
                Article
                10.1053/j.gastro.2023.01.029
                e5a95c72-c6bf-46df-9ea1-c88cbcdf9d82
                © 2023

                https://www.elsevier.com/tdm/userlicense/1.0/

                History

                Comments

                Comment on this article